伟思医疗
(688580)
| 流通市值：42.49亿 | | | 总市值：42.49亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,059,037,112.46 | 1,068,159,804.95 | 627,053,203.57 | 1,027,846,530.53 |
| 应收票据及应收账款 | 23,388,812.25 | 25,152,299.37 | 37,105,103.52 | 39,761,185.24 |
| 应收账款 | 23,388,812.25 | 25,152,299.37 | 37,105,103.52 | 39,761,185.24 |
| 预付款项 | 8,699,859.33 | 6,016,013.48 | 6,794,940.26 | 6,926,509.8 |
| 其他应收款合计 | 6,125,166.51 | 5,320,763.83 | 6,680,688.18 | 5,353,215.03 |
| 存货 | 36,298,586.4 | 38,737,651.18 | 38,689,575.59 | 44,511,691.66 |
| 其他流动资产 | 21,876,780.76 | 19,885,850.68 | 20,727,458.18 | 17,003,721.13 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,155,426,317.71 | 1,163,272,383.49 | 1,137,050,969.3 | 1,141,402,853.39 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 24,455,419.47 | 24,455,419.47 | 22,035,950.26 | 22,035,950.26 |
| 固定资产 | 395,065,829.18 | 87,831,024.03 | 89,659,419.08 | 91,879,055.34 |
| 在建工程 | 15,283,018.87 | 319,830,830.45 | 300,559,120.71 | 273,098,697.81 |
| 使用权资产 | 2,078,708.83 | 2,443,225.33 | 506,815.65 | 557,497.23 |
| 无形资产 | 120,683,302.34 | 122,395,268.99 | 103,162,228.45 | 104,666,728.3 |
| 开发支出 | 7,862,570.14 | 5,288,405.65 | 21,574,007.39 | 18,355,677.23 |
| 商誉 | 69,306,067.79 | 69,306,067.79 | 69,306,067.79 | 69,306,067.79 |
| 长期待摊费用 | 1,982,675.64 | 2,073,358.61 | 2,354,238.24 | 2,635,495.11 |
| 递延所得税资产 | 13,675,931.68 | 13,405,183.56 | 19,161,878.92 | 18,721,302.51 |
| 其他非流动资产 | 10,139,433.38 | 10,063,545.83 | 10,033,474.63 | 1,289,461.73 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 660,532,957.32 | 657,092,329.71 | 638,353,201.12 | 602,545,933.31 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,815,959,275.03 | 1,820,364,713.2 | 1,775,404,170.42 | 1,743,948,786.7 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 14,466,093.63 | 19,404,406.21 | 12,433,483.32 | 19,177,865.98 |
| 应付账款 | 14,466,093.63 | 19,404,406.21 | 12,433,483.32 | 19,177,865.98 |
| 预收款项 | 922,649.81 | 1,190,762.81 | 873,549.7 | 930,407.61 |
| 合同负债 | 2,479,221.28 | 3,631,330.16 | 3,291,266.27 | 3,642,199.24 |
| 应付职工薪酬 | 9,312,389.1 | 22,916,761.79 | 8,743,417.8 | 9,217,331.64 |
| 应交税费 | 13,034,797.25 | 10,472,188.43 | 12,029,130.4 | 9,415,322.33 |
| 其他应付款合计 | 82,813,855.95 | 104,607,669.33 | 94,772,519.17 | 95,895,615.83 |
| 一年内到期的非流动负债 | 29,344,784.02 | 29,143,867.36 | - | - |
| 其他流动负债 | 78,690.25 | 222,313.19 | - | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 152,452,481.29 | 191,589,299.28 | 132,143,366.66 | 138,278,742.63 |
| 非流动负债: | | | | |
| 租赁负债 | 1,006,511.58 | 896,826.38 | 450,103.58 | 507,787.43 |
| 长期应付款 | - | - | 28,069,419.35 | 27,747,561.2 |
| 递延收益 | - | - | 2,090,564.97 | 3,361,843.22 |
| 递延所得税负债 | 399,179.38 | 415,698.21 | 432,155.84 | 448,687.82 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,405,690.96 | 1,312,524.59 | 31,042,243.74 | 32,065,879.67 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 153,858,172.25 | 192,901,823.87 | 163,185,610.4 | 170,344,622.3 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 95,771,288 | 95,771,288 | 95,771,288 | 95,771,288 |
| 资本公积 | 1,063,033,737.58 | 1,064,951,007.78 | 1,074,982,826.68 | 1,095,829,523.88 |
| 减:库存股 | 2,433,676.45 | 5,769,085.05 | 7,242,279.07 | 38,157,501.7 |
| 盈余公积 | 47,885,644 | 44,612,457.28 | 34,311,933.5 | 34,311,933.5 |
| 未分配利润 | 457,844,109.65 | 427,897,221.32 | 414,394,790.91 | 385,848,920.72 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,662,101,102.78 | 1,627,462,889.33 | 1,612,218,560.02 | 1,573,604,164.4 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,662,101,102.78 | 1,627,462,889.33 | 1,612,218,560.02 | 1,573,604,164.4 |
| 负债和股东权益合计 | 1,815,959,275.03 | 1,820,364,713.2 | 1,775,404,170.42 | 1,743,948,786.7 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-25 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |